Reversal of endotoxin-induced hypotension by inhibition of inducible nitric oxide synthase activity is associated with improved oxidative status in rat heart, aorta and mesenteric artery

Turkish Journal of Medical Sciences

Volumn 36, Issue 2, 2006, Pages 71-80

  Tunçtan, Bahar ^a   Korkmaz, Belma ^a   Yildirim, Hatice ^a   Tamer, Lülüfer ^a   Atik, Uǧur ^a   Buharalioǧlu, C Kemal ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Endotoxin; Hypotension; Inducible nitric oxide synthase; Lipid peroxidation; Rat

Indexed keywords

ANTIOXIDANTS; ENZYMES; LIPIDS; PEROXIDES; RESTORATION; TISSUE;

ENDOTOXIN-INDUCED HYPOTENSION; HYPOTENSION; MESENTERIC ARTERY; MYELOPEROXIDASE; NITRIC OXIDE; OXIDATIVE STRESS; TOTAL ANTIOXIDANT CAPACITY; VASCULAR HYPOREACTIVITY;

BIOMEDICAL ENGINEERING;

ESCHERICHIA COLI ENDOTOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PHENYLENE 1,3 BIS(ETHANE 2 ISOTHIOUREA)DIHYDROBROMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; CONSCIENCE; CONSCIOUSNESS; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; HEART; HYPOTENSION; INJECTION; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; OXIDATIVE STRESS; RAT; RAT STRAIN; SERUM;

EID: 33645559097     PISSN: 13000144     EISSN: 13036165     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Victor VM, Rocha M, De la Fuente M. Immune cells: free radicals and antioxidant in sepsis. Int Immunopharmacol 4: 327-47, 2004.
2. Cadenas S, Cadenas AM. Fighting the stranger-antioxidant protection against endotoxin toxicity. Toxicology 18: 45-63, 2002.
3. Cuzzocrea S, Riley DP, Caputi AP et al. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53: 135-59, 2001.
4. Salvemini D, Cuzzocrea S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 33: 1173-85, 2002.
5. Pascual C, Karzai W, Meier-Hellmann A et al. Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 26: 705-9, 1998.
6. Batra S, Kumar R, Seema R et al. Alterations in antioxidant status during neonatal sepsis. Ann Trop Paediatr 20: 27-33, 2000.
7. Tunctan B, Altug S. The use of nitric oxide synthase inhibitors in inflammatory diseases: a novel class of anti-inflammatory agents. Curr Med Chem: Anti-Inflammatory & Anti-Allergy Agents 3: 271-301, 2004.
8. Tunctan B, Yaghini FA, Estes A et al. Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. FASEB Suppl 18: A1034-5, 2004.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-54, 1976.
10. Butler AR, Flitney FW, Williams DLH. NO, nitrosonium ions, nitroxide ions, and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol Sci 16: 18-22, 1995.
11. Ignarro LJ, Fukuto JM, Griscavage JM et al. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci USA 90, 8103-7, 1993.
12. Tunctan B, Uludag O, Altug S et al. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol Res 38: 405-411, 1998.
13. Tunctan B, Altug S, Uludag O et al. Time-dependent variations in serum nitrite, 6-keto-prostaglandin F1a and thromboxane B2 levels induced by lipopolysaccharide in mice. Biol Rhythm Res 31: 499-514, 2000.
14. Tunctan B, Altug S, Uludag O et al. Effects of cyclooxygenase inhibitors on nitric oxide production and survival in a mice model of sepsis. Pharmacol Res 48: 37-48, 2003.
15. Chance B, Maehley AC. Assay of catalases and peroxidases. Methods in Enzymology (Eds. S Colowick and N Kaplan) Academic Press, New York, 1955, pp: 764-775.
16. Yagi K. Lipid peroxides and related radicals in clinical medicine. Free Radicals in Diagnostic Medicine. (Ed. D Armstrong) Plenum Press, New York 1994, pp: 1-15.
17. Cuzzocrea C. Effect of inhibitors of nitric oxide in animal models and future directions for therapy in inflammatory disorders. Curr Med Chem Anti-Inflammatory & Anti-Allergy Agents 3: 261-70, 2004.
18. Blantz RC, Munger K. Role of nitric oxide in inflammatory conditions. Nephron 90: 373-8, 2002.
19. Wu CC. Nitric oxide and inflammation. Curr Med Chem: Anti-Inflammatory & Anti-Allergy Agents 3: 217-22, 2004.
20. Mirochnitchenko O, Prokopenko O, Palnitkar U et al. Endotoxemia in transgenic mice overexpressing human glutathione peroxidases. Circ Res 87: 289-95, 2000.
21. Bloodsworth A, O'Donnell VB, Freeman BA. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol 20: 1707-15, 2000.
22. d'Ischia M, Palumbo A, Buzzo F. Interactions of nitric oxide with lipid peroxidation products under aerobic conditions: inhibitory effects on the formation of malondialdehyde and related thiobarbituric acid-reactive substances. Nitric Oxide: Biol Chem 4: 4-14, 2000.
23. Hogg N, Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochim Biophys Acta 1411: 378-84, 1999.
24. Wink DA, Miranda KM, Espey MG et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 3: 203-13, 2001.
25. Kelley EE, Wagner BA, Buettner GR et al. Nitric oxide inhibits iron-induced lipid peroxidation in HL-60 cells. Arch Biochem Biophys 370: 97-104, 1999.
26. d'Ischia M, Palumbo A, Buzzo F. Interactions of nitric oxide with lipid peroxidation products under aerobic conditions: inhibitory effects on the formation of malondialdehyde and related thiobarbituric acid-reactive substances. Nitric Oxide 4: 4-14, 2000.
27. Brady TC, Crapo JD, Mercer RR. Nitric oxide inhalation transiently elevates pulmonary levels of cGMP, iNOS mRNA, and TNF-alpha. Am J Physiol 275: L509-15, 1998.
28. Yavuz T, Altuntas I, Odabasi D et al. Beneficial effect of the addition of nitroglycerin to the cardioplegic solution on lipid peroxidation during coronary artery bypass surgery. Int Heart J 46: 45-55, 2005.
29. Kwiecien S, Brzozowski T, Konturek PC et al. The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions. J Physiol Pharmacol 53: 761-73, 2002.
30. Husain K. Interaction of physical training and chronic nitroglycerin treatment on blood pressure, nitric oxide, and oxidants/antioxidants in the rat heart. Pharmacol Res 48: 253-61, 2003.
31. Rahman A, Ahmed S, Vasenwala SM et al. Glyceryl trinitrate, a nitric oxide donor, abrogates ferric nitrilotriacetate-induced oxidative stress and renal damage. Arch Biochem Biophys 418: 71-9, 2003.
32. Konturek PC, Brzozowski T, Ptak A et al. Nitric oxide releasing aspirin protects the gastric mucosa against stress and promotes healing of stress-induced gastric mucosal damage: role of heat shock protein 70. Digestion 66: 160-72, 2002.
33. Zhu W, Fung PC. The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl(4)-induced acute liver injury of mice. Free Radic Biol Med 29: 870-80, 2000.
34. Utepbergenov DI, Mertsch K, Sporbert A et al. Nitric oxide protects blood-brain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS Lett 424: 197-201, 1998.
35. Rauhala P, Sziraki I, Chiueh CC. Peroxidation of brain lipids in vitro: nitric oxide versus hydroxyl radicals. Free Radic Biol Med 21: 391-4, 1996.
36. Ozturk H, Aldemir M, Dokucu AI et al. The nitric oxide donor molsidomine prevents ischemia/reperfusion injury of the adult rat small intestine. Pediatr Surg Int 19: 305-8, 2003.
37. Li C, Liu J, Saavedra JE et al. The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced nephrotoxicity in mice. Toxicology 189: 173-80, 2003.
38. Brzozowski T, Konturek PC, Konturek SJ et al. Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin. Int J Colorectal Dis 18: 320-9, 2003.
39. Dhawan V, Handu SS, Nain CK et al. Chronic L-arginine supplementation improves endothelial cell vasoactive functions in hypercholesterolemic and atherosclerotic monkeys. Mol Cell Biochem 269: 1-11, 2005.
40. Kabaroglu C, Akisu M, Habif S et al. Effects of L-arginine and L-carnitine in hypoxia/reoxygenation-induced intestinal injury. Pediatr Int 47: 10-4, 2005.
41. Zilan A, Cetinkale O, Kiran B et al. The role of supplementation or inhibition of nitric oxide production in burn injury to reduce ischemic damage. Ulus Travma Derg 9: 169-75, 2003.
42. Burra P, Chirizzi L, Cardin R et al. Warm hepatic ischemia in pigs: effects of L-arginine and oligotide treatment. J Invest Surg 14: 303-12, 2001.
43. Kilic I, Kilic BA, Guven C et al. Role of nitric oxide in hypoxia-induced changes in newborn rats. Biol Neonate 78: 191-7, 2000.
44. Morita K, Sherman MP, Buckberg GD et al. Studies of hypoxemic/ reoxygenation injury: without aortic clamping. V. Role of the L-arginine-nitric oxide pathway: the nitric oxide paradox. J Thorac Cardiovasc Surg 110: 1200-11, 1995.
45. Kiziltepe U, Tunctan B, Bastuzel Eyileten Z et al. Efficiency of L-arginine enriched cardioplegia and non-cardiopegic reperfusion in ischaemic hearts. Int J Cardiol 97, 93-100, 2004.
46. Guzman DC, Vazquez IE, Mejia GB et al. Comparative effect of cyanamide and sodium nitroprusside on indolamine and lipid peroxidation levels in rat brain. Proc West Pharmacol Soc 47: 105-8, 2004.
47. Siu AW, To CH. Nitric oxide and hydroxyl radical-induced retinal lipid peroxidation in vitro. Clin Exp Optom 85: 378-82, 2002.
48. Siu AW, Reiter RJ, To CH. Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J Pineal Res 27: 122-8, 1999.
49. Inal ME, Eguz AM. The effects of isosorbide dinitrate on methemoglobin reductase enzyme activity and antioxidant states. Cell Biochem Funct 22: 129-33, 2004.
50. Deaciuc IV, D'Souza NB, Sarphie TG et al. Effects of exogenous superoxide anion and nitric oxide on the scavenging function and electron microscopic appearance of the sinusoidal endothelium in the isolated, perfused rat liver. J Hepatol 30: 213-21, 1999.
51. Rhoden EL, Lucas ML, Pereira-Lima L et al. Effects of L-arginine on the kidney levels of malondialdehyde in rats submitted to renal ischaemia- reperfusion. BJU Int 88: 273-7, 2001.
52. Rhoden EL, Rhoden CR, Lucas ML et al. The role of nitric oxide pathway in the renal ischemia-reperfusion injury in rats. Transpl Immunol 10: 277-84, 2002.
53. Seven A, Seymen O, Inci F et al. Evaluation of oxidative stress in experimental colitis: effects of L-arginine-nitric oxide pathway manipulation. J Toxicol Environ Health A 61: 167-76, 2000.
54. Mori E, Haramaki N, Ikeda H et al. Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs. Cardiovasc Res 40: 113-23, 1998.
55. Sauebin L, Rossi A, Serraino I et al. Effect of anthocyanins contained in a blackberry extract on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Planta Med 70: 745-52, 2004.
56. Shen KP, Lo YC, Yang RC et al. Antioxidant eugenosedin-A protects against lipopolysaccharide-induced hypotension, hyperglycaemia and cytokine immunoreactivity in rats and mice. J Pharm Pharmacol 57: 117-25, 2005.
57. Liaw SJ, Chen JC, Ng CJ et al. Beneficial role of melatonin on microcirculation in endotoxin-induced gastropathy in rats: possible implication in nitrogen oxide reduction. J Formos Med Assoc 101: 129-35, 2002.
58. Altavilla D, Squadrito G, Minutoli L et al. Inhibition of nuclear factor-kappaB activation by IRFI 042, protects against endotoxin-induced shock. Cardiovasc Res 54: 684-93, 2002.
59. Hauser B, Kick J, Asfar P et al. Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia. Crit Care Med 33: 2034-42, 2005.
60. Altavilla D, Squadrito F, Serrano M et al. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats. Br J Pharmacol 124: 1293-9, 1998.
61. Bermejo A, Zarzuelo A, Duarte J. In vivo vascular effects of genistein on a rat model of septic shock induced by lipopolysaccharide. J Cardiovasc Pharmacol 42: 329-38, 2003.